earnings
NASDAQ · AKTX
Akari Therapeutics, Plc
Healthcare · Biotechnology
$6.80
Up+$0.29 (+4.45%)
Updated Nov 15, 2026, 7:55 AM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.22K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $0.13 – $29.32
- Volume
- 21.43K
- Avg. volume
- 1.09M
Price performance · AKTX
AKTX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
AKTX closed at $6.80 after 20 trading sessions, down 31.24% for the selected period.
- Last close
- $6.80
- Period change
- -31.24%
- Period low
- $6.51
- Period high
- $9.89
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $6.52 | $7.5473 | $6.52 | $6.80 | 21.43K |
| Nov 12, 2026 | $7.49 | $7.69 | $6.51 | $6.51 | 14.52K |
| Nov 11, 2026 | $7.18 | $7.65 | $7.156 | $7.45 | 22.51K |
| Nov 10, 2026 | $7.82 | $7.82 | $6.91 | $7.13 | 26.99K |
| Nov 9, 2026 | $7.54 | $7.89 | $7.33 | $7.66 | 42.95K |
| Nov 6, 2026 | $7.77 | $8.375 | $7.27 | $7.3701 | 53.06K |
| Nov 5, 2026 | $8.80 | $9.025 | $7.60 | $7.75 | 31.88K |
| Nov 4, 2026 | $8.13 | $9.38 | $8.13 | $9.29 | 86.92K |
| Nov 3, 2026 | $8.39 | $8.61 | $7.9902 | $8.1505 | 63.28K |
| Nov 2, 2026 | $8.40 | $8.40 | $7.56 | $7.84 | 11.86K |
| Oct 30, 2026 | $8.50 | $8.97 | $8.0706 | $8.24 | 45.8K |
| Oct 29, 2026 | $9.17 | $9.8299 | $8.00 | $8.00 | 97.01K |
| Oct 28, 2026 | $8.665 | $9.325 | $8.29 | $9.20 | 42.29K |
| Oct 27, 2026 | $7.94 | $8.64 | $7.94 | $8.58 | 38.46K |
| Oct 26, 2026 | $7.64 | $8.45 | $7.63 | $7.63 | 67.84K |
| Oct 23, 2026 | $8.00 | $8.45 | $7.84 | $8.225 | 14.4K |
| Oct 22, 2026 | $8.69 | $9.115 | $7.58 | $8.10 | 20.89K |
| Oct 21, 2026 | $9.29 | $9.9387 | $8.70 | $8.76 | 30.6K |
| Oct 20, 2026 | $9.15 | $9.7249 | $9.15 | $9.29 | 35.12K |
| Oct 19, 2026 | $9.01 | $10.00 | $8.52 | $9.89 | 79.08K |
Latest AKTX news
The latest Smart Investors Daily articles mentioning AKTX.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…